Elder Pharmaceuticals has said it is acquiring a UK-based company through its wholly-owned subsidiary In Dubai, Elder Pharma said in a filing to the National Stock Exchange on Thursday.
Elder Pharma is engaged in manufacture, research and development and marketing of pharmaceutical products.
According to a Reuters report, Elder will buy NeutraHealth, a UK-based supplier of vitamins and nutrients, for about £12.2 million (approximately 8.77 billion rupees). If the deal gets through Neutrahealth shareholders will get 6.5 pence per share, a 20.9 percent premium on Wednesday’s close.
Source: IB Times